PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $439,000 | +275.2% | 24,385 | +48.4% | 0.00% | +100.0% |
| Q1 2020 | $117,000 | -83.0% | 16,430 | -43.0% | 0.00% | -66.7% |
| Q4 2019 | $689,000 | -17.6% | 28,844 | -7.4% | 0.00% | -40.0% |
| Q3 2019 | $836,000 | +8.3% | 31,162 | +9.6% | 0.01% | 0.0% |
| Q2 2019 | $772,000 | -31.1% | 28,439 | -12.0% | 0.01% | -28.6% |
| Q1 2019 | $1,121,000 | +83.5% | 32,317 | +3.2% | 0.01% | +75.0% |
| Q4 2018 | $611,000 | -38.4% | 31,323 | -15.9% | 0.00% | -42.9% |
| Q3 2018 | $992,000 | -30.5% | 37,247 | -1.5% | 0.01% | -30.0% |
| Q2 2018 | $1,428,000 | +11.8% | 37,802 | -3.3% | 0.01% | +25.0% |
| Q1 2018 | $1,277,000 | -42.2% | 39,111 | -13.8% | 0.01% | -46.7% |
| Q4 2017 | $2,208,000 | +8.2% | 45,355 | +20.0% | 0.02% | -21.1% |
| Q3 2017 | $2,041,000 | +4.3% | 37,783 | +8.4% | 0.02% | 0.0% |
| Q2 2017 | $1,957,000 | +34.8% | 34,848 | -5.9% | 0.02% | +26.7% |
| Q1 2017 | $1,452,000 | +40.4% | 37,051 | -19.6% | 0.02% | +36.4% |
| Q4 2016 | $1,034,000 | +8.2% | 46,078 | +9.4% | 0.01% | -15.4% |
| Q3 2016 | $956,000 | -18.8% | 42,100 | -15.7% | 0.01% | -13.3% |
| Q2 2016 | $1,178,000 | +17.7% | 49,933 | +1.8% | 0.02% | +7.1% |
| Q1 2016 | $1,001,000 | -62.4% | 49,058 | -5.2% | 0.01% | -56.2% |
| Q4 2015 | $2,662,000 | +34.6% | 51,743 | +11.5% | 0.03% | +14.3% |
| Q3 2015 | $1,978,000 | -8.4% | 46,419 | -2.1% | 0.03% | -6.7% |
| Q2 2015 | $2,160,000 | +20.0% | 47,418 | -0.0% | 0.03% | +42.9% |
| Q1 2015 | $1,800,000 | +53.6% | 47,419 | +14.6% | 0.02% | +50.0% |
| Q4 2014 | $1,172,000 | +28.9% | 41,369 | +15.0% | 0.01% | +16.7% |
| Q3 2014 | $909,000 | -27.5% | 35,976 | -16.2% | 0.01% | -25.0% |
| Q2 2014 | $1,253,000 | +16.8% | 42,939 | +3.6% | 0.02% | +23.1% |
| Q1 2014 | $1,073,000 | +128.8% | 41,443 | +127.5% | 0.01% | +85.7% |
| Q4 2013 | $469,000 | – | 18,219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |